Bioanalytical procedures for monitoring in utero drug exposure.
about
Prenatal nicotine exposure and child behavioural problems.Hair and plasma data show that lopinavir, ritonavir, and efavirenz all transfer from mother to infant in utero, but only efavirenz transfers via breastfeedingDevelopment and validation of a liquid chromatography-atmospheric pressure chemical ionization-tandem mass spectrometry method for simultaneous analysis of 10 amphetamine-, methamphetamine- and 3,4-methylenedioxymethamphetamine-related (MDMA) analytNicotine and metabolites in meconium as evidence of maternal cigarette smoking during pregnancy and predictors of neonatal growth deficitsPrenatal methadone exposure, meconium biomarker concentrations and neonatal abstinence syndrome.Effect of hydrolysis on identifying prenatal cannabis exposureDevelopment and validation of a liquid chromatography mass spectrometry assay for the simultaneous quantification of methadone, cocaine, opiates and metabolites in human umbilical cord.A liquid chromatography tandem mass spectrometry method for the simultaneous quantification of 20 drugs of abuse and metabolites in human meconiumUHPLC-MS/MS quantification of buprenorphine, norbuprenorphine, methadone, and glucuronide conjugates in umbilical cord plasma.Antiretroviral Drugs in Meconium: Detection for Different Gestational Periods of Exposure.Validation of a novel method to identify in utero ethanol exposure: simultaneous meconium extraction of fatty acid ethyl esters, ethyl glucuronide, and ethyl sulfate followed by LC-MS/MS quantification.Meconium Tenofovir Concentrations and Growth and Bone Outcomes in Prenatally Tenofovir Exposed HIV-Uninfected ChildrenDevelopment and validation of the first liquid chromatography-tandem mass spectrometry assay for simultaneous quantification of multiple antiretrovirals in meconium.The feasibility and cost of neonatal screening for prenatal alcohol exposure by measuring phosphatidylethanol in dried blood spots.Meconium Atazanavir Concentrations and Early Language Outcomes in HIV-Exposed Uninfected Infants With Prenatal Atazanavir Exposure.Predictors of neonatal abstinence syndrome in buprenorphine exposed newborn: can cord blood buprenorphine metabolite levels help?Objective Testing: Urine and Other Drug TestsPrenatal tobacco exposure, biomarkers for tobacco in meconium, and neonatal growth outcomes.Validation and application of a method for the determination of buprenorphine, norbuprenorphine, and their glucuronide conjugates in human meconiumSimultaneous quantification of buprenorphine, norbuprenorphine, buprenorphine-glucuronide and norbuprenorphine-glucuronide in human umbilical cord by liquid chromatography tandem mass spectrometry.Confirmatory analysis of buprenorphine, norbuprenorphine, and glucuronide metabolites in plasma by LCMSMS. Application to umbilical cord plasma from buprenorphine-maintained pregnant women.Determination of amphetamine and methamphetamine in umbilical cord using liquid chromatography-tandem mass spectrometry.Identification of prenatal amphetamines exposure by maternal interview and meconium toxicology in the Infant Development, Environment and Lifestyle (IDEAL) study.Collection of biological samples in forensic toxicology.Maternal-infant biomonitoring of environmental chemicals: the epidemiologic challenges.Bioanalytical methods for the determination of cocaine and metabolites in human biological samples.Hair: a complementary source of bioanalytical information in forensic toxicology.Hair as an alternative matrix in bioanalysis.Trends in drug testing in oral fluid and hair as alternative matrices.Bioanalysis during pregnancy: recent advances and novel sampling strategies.Maternal and neonatal hair and breast milk in the assessment of perinatal exposure to drugs of abuse.Bioanalysis for cocaine, opiates, methadone, and amphetamines exposure detection during pregnancy.The interstitial lymphatic peritoneal mesothelium axis in portal hypertensive ascites: when in danger, go back to the sea.Sensitive Quantification of Cannabinoids in Milk by Alkaline Saponification-Solid Phase Extraction Combined with Isotope Dilution UPLC-MS/MS.Pathological axes of wound repair: gastrulation revisited.Prevention inherent in services for women with schizophrenia.Incidence of fetal drug exposure in Alabama: 2004-2011.Detection of in utero cannabis exposure by umbilical cord analysis.A rapid assay for the simultaneous determination of nicotine, cocaine and metabolites in meconium using disposable pipette extraction and gas chromatography-mass spectrometry (GC-MS).Simultaneous determination of opiates, methadone, amphetamines, cocaine, and metabolites in human placenta and umbilical cord by LC-MS/MS.
P2860
Q27690867-9D852528-38C6-4959-A131-D174186F87A7Q30679524-8E54B1A0-F255-480E-AB09-581187E21E5DQ33439633-31AF05BF-9039-4D65-AD48-74815EA0282FQ33885954-89CCA652-4136-4798-954D-6EF1F3D37FADQ34288414-CD9923AB-6BFB-4474-A095-B05D4F86D5FFQ35184670-215FE2C2-0E72-466A-9FBA-FA0DE40D185BQ35184678-EE35E5B3-0CAB-4838-AC4A-C698DFFF8290Q35190477-4F3E26B8-A5DE-44D0-9FFB-0555B9D00693Q35586688-5FA23AB8-162D-4F03-A9DC-DC1F5738C0D6Q35894019-19301247-51FE-45DF-A2B3-26B8A2E49536Q35962908-694DEBB6-C2E1-4AA6-8A22-9C477F97E462Q36070335-0DD9630F-8589-4D84-99FA-4902EAF55C35Q36800100-56513941-B9C7-458A-80E1-11C8814A89AFQ36867713-70C43267-6E42-4439-A07A-751F4352E7F9Q36951911-2B8C7D0F-60CD-4445-A0D2-99752E7ADD65Q37033834-FFC82AAF-E281-41CC-883F-482A9A0AE13DQ37037872-82669DB8-C20C-48FA-83E0-375EF335A59EQ37100390-B923FBC5-7F81-4292-8C5F-97634B77267AQ37210263-29CCF686-C874-4E10-B2CB-E007AE0023BDQ37236830-A95B2B60-1F1C-4212-A6BD-BB1764929027Q37351683-2DAB39DC-C966-4DBC-BEC4-9232A9A4723AQ37434781-FD998FAC-6806-484D-B9E3-82A1445D11AAQ37443990-6D004B85-1CD5-4384-8070-D1F19D63EF59Q37771033-AAE6DD1C-E137-4CA5-8D8B-37992AD9F423Q37779762-681FE26B-1BDA-4A15-B60E-E67F8050BBB4Q37810146-23197708-BDD8-4BB5-AA23-20A22054CC8FQ37822786-2668032E-2007-4BD2-BF6E-D39885DE4E58Q38099401-5EF2FBAC-E861-4FC4-B49C-0E280232B76AQ38266511-AF83894E-4F55-490D-810D-91ABE8E60504Q38296225-AFF3DA33-CCA3-44BE-8320-1E311C8F9F66Q38516618-7A4BD00E-1A2C-4EE1-A4DF-6C700FA76292Q39422252-3C303BC2-3B06-44EF-8D6F-E3A1A58E76A3Q41666713-717024ED-A833-4B8B-826E-808E5E5B8FE3Q41690674-DCDFB4DB-CED9-4E4C-8B36-EF371B7B89F7Q41821875-423C3288-E74A-4CA2-ACD4-0E15BB3603AEQ44740392-709EC798-B4F9-408D-9F8D-A4E737D4C3AEQ46317467-EA7E242A-18B7-458A-98A6-B1E11D90651FQ47921404-D559E663-46EE-4A88-BCCD-E60103210B34Q47945346-04637B00-9B89-4F2A-92CE-07C32F35CC37Q48091451-4800959A-6B6B-41B7-BF4A-32268703043C
P2860
Bioanalytical procedures for monitoring in utero drug exposure.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Bioanalytical procedures for monitoring in utero drug exposure.
@ast
Bioanalytical procedures for monitoring in utero drug exposure.
@en
type
label
Bioanalytical procedures for monitoring in utero drug exposure.
@ast
Bioanalytical procedures for monitoring in utero drug exposure.
@en
prefLabel
Bioanalytical procedures for monitoring in utero drug exposure.
@ast
Bioanalytical procedures for monitoring in utero drug exposure.
@en
P2860
P1476
Bioanalytical procedures for monitoring in utero drug exposure.
@en
P2093
Marilyn Huestis
Teresa Gray
P2860
P2888
P304
P356
10.1007/S00216-007-1228-9
P407
P577
2007-03-17T00:00:00Z